• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基质辅助激光解吸电离飞行时间质谱法用于细胞因子巨噬细胞移动抑制因子(MIF)的定性和定量分析

Mass Spectrometric Immunoassay for the qualitative and quantitative analysis of the cytokine Macrophage Migration Inhibitory Factor (MIF).

机构信息

The Biodesign Institute at Arizona State University, Tempe, AZ 85287 USA.

The Biodesign Institute at Arizona State University, Tempe, AZ 85287 USA ; Department of Chemistry & Biochemistry at Arizona State University, Tempe, AZ 85287 USA.

出版信息

Proteome Sci. 2014 Oct 14;12(1):52. doi: 10.1186/s12953-014-0052-3. eCollection 2014.

DOI:10.1186/s12953-014-0052-3
PMID:25328446
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4201675/
Abstract

BACKGROUND

The cytokine MIF (Macrophage Migration Inhibitory Factor) has diverse physiological roles and is present at elevated concentrations in numerous disease states. However, its molecular heterogeneity has not been previously investigated in biological samples. Mass Spectrometric Immunoassay (MSIA) may help elucidate MIF post-translational modifications existing in vivo and provide additional clarity regarding its relationship to diverse pathologies.

RESULTS

In this work, we have developed and validated a fully quantitative MSIA assay for MIF, and used it in the discovery and quantification of different proteoforms of MIF in serum samples, including cysteinylated and glycated MIF. The MSIA assay had a linear range of 1.56-50 ng/mL, and exhibited good precision, linearity, and recovery characteristics. The new assay was applied to a small cohort of human serum samples, and benchmarked against an MIF ELISA assay.

CONCLUSIONS

The quantitative MIF MSIA assay provides a sensitive, precise and high throughput method to delineate and quantify MIF proteoforms in biological samples.

摘要

背景

细胞因子 MIF(巨噬细胞移动抑制因子)具有多种生理作用,在许多疾病状态下其浓度升高。然而,其在生物样本中的分子异质性尚未得到研究。质谱免疫分析(MSIA)可能有助于阐明体内存在的 MIF 翻译后修饰,并为其与多种病理的关系提供更多的明确信息。

结果

在这项工作中,我们开发并验证了一种用于 MIF 的完全定量 MSIA 测定法,并将其用于在血清样本中发现和定量不同形式的 MIF,包括半胱氨酸化和糖化 MIF。MSIA 测定法的线性范围为 1.56-50ng/mL,具有良好的精密度、线性和回收率特征。新测定法应用于一小部分人血清样本,并与 MIF ELISA 测定法进行了基准测试。

结论

定量 MIF MSIA 测定法提供了一种灵敏、精确和高通量的方法,可用于描绘和定量生物样本中的 MIF 蛋白形式。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98fc/4201675/1250541081e1/12953_2014_52_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98fc/4201675/cde6e710cb6c/12953_2014_52_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98fc/4201675/c1a7c1e5a4ef/12953_2014_52_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98fc/4201675/da3e2f4822a0/12953_2014_52_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98fc/4201675/46226e1c6a73/12953_2014_52_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98fc/4201675/1250541081e1/12953_2014_52_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98fc/4201675/cde6e710cb6c/12953_2014_52_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98fc/4201675/c1a7c1e5a4ef/12953_2014_52_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98fc/4201675/da3e2f4822a0/12953_2014_52_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98fc/4201675/46226e1c6a73/12953_2014_52_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98fc/4201675/1250541081e1/12953_2014_52_Fig5_HTML.jpg

相似文献

1
Mass Spectrometric Immunoassay for the qualitative and quantitative analysis of the cytokine Macrophage Migration Inhibitory Factor (MIF).基质辅助激光解吸电离飞行时间质谱法用于细胞因子巨噬细胞移动抑制因子(MIF)的定性和定量分析
Proteome Sci. 2014 Oct 14;12(1):52. doi: 10.1186/s12953-014-0052-3. eCollection 2014.
2
Quantitative mass spectrometric immunoassay for the chemokine RANTES and its variants.趋化因子RANTES及其变体的定量质谱免疫分析。
J Proteomics. 2015 Feb 26;116:15-23. doi: 10.1016/j.jprot.2014.12.011. Epub 2014 Dec 27.
3
Development of quantitative mass spectrometric immunoassay for serum amyloid A.血清淀粉样蛋白A定量质谱免疫分析方法的开发
Biomarkers. 2016 Dec;21(8):743-751. doi: 10.1080/1354750X.2016.1201533. Epub 2016 Jul 22.
4
Parallel workflow for high-throughput (>1,000 samples/day) quantitative analysis of human insulin-like growth factor 1 using mass spectrometric immunoassay.使用质谱免疫分析法对人胰岛素样生长因子1进行高通量(每天>1000个样本)定量分析的并行工作流程。
PLoS One. 2014 Mar 24;9(3):e92801. doi: 10.1371/journal.pone.0092801. eCollection 2014.
5
Development of multiplex mass spectrometric immunoassay for detection and quantification of apolipoproteins C-I, C-II, C-III and their proteoforms.用于检测和定量载脂蛋白C-I、C-II、C-III及其蛋白变体的多重质谱免疫分析方法的开发。
Methods. 2015 Jun 15;81:86-92. doi: 10.1016/j.ymeth.2015.02.020. Epub 2015 Mar 7.
6
Targeted quantitative mass spectrometric immunoassay for human protein variants.靶向定量质谱免疫分析法检测人蛋白变异体。
Proteome Sci. 2011 Apr 8;9(1):19. doi: 10.1186/1477-5956-9-19.
7
A semi-automated mass spectrometric immunoassay coupled to selected reaction monitoring (MSIA-SRM) reveals novel relationships between circulating PCSK9 and metabolic phenotypes in patient cohorts.一种与选择反应监测相结合的半自动质谱免疫分析方法(MSIA-SRM)揭示了患者队列中循环PCSK9与代谢表型之间的新关系。
Methods. 2015 Jun 15;81:66-73. doi: 10.1016/j.ymeth.2015.03.003. Epub 2015 Mar 11.
8
Quantitative mass spectrometry evaluation of human retinol binding protein 4 and related variants.定量质谱法评估人视黄醇结合蛋白 4 及其相关变体。
PLoS One. 2011 Mar 30;6(3):e17282. doi: 10.1371/journal.pone.0017282.
9
Macrophage migration inhibitory factor evaluation compared with prostate specific antigen as a biomarker in patients with prostate carcinoma.与前列腺特异性抗原相比,巨噬细胞移动抑制因子作为前列腺癌患者生物标志物的评估
Cancer. 2002 Mar 1;94(5):1449-56. doi: 10.1002/cncr.10354.
10
Assessment of macrophage migration inhibitory factor in humans: protocol for accurate and reproducible levels.人类巨噬细胞移动抑制因子的评估:准确和可重复水平的方案。
Free Radic Biol Med. 2013 Oct;63:236-42. doi: 10.1016/j.freeradbiomed.2013.05.018. Epub 2013 May 22.

引用本文的文献

1
Association of Cystatin C Proteoforms with Estimated Glomerular Filtration Rate.胱抑素C蛋白异构体与估算肾小球滤过率的关联
Clin Mass Spectrom. 2016 Nov;1:27-31. doi: 10.1016/j.clinms.2016.11.001. Epub 2016 Nov 14.
2
Distinct patterns of serum and urine macrophage migration inhibitory factor kinetics predict death in sepsis: a prospective, observational clinical study.血清和尿液巨噬细胞迁移抑制因子动力学的不同模式可预测脓毒症患者的死亡:一项前瞻性、观察性临床研究。
Sci Rep. 2023 Jan 11;13(1):588. doi: 10.1038/s41598-023-27506-6.
3
The Human Proteoform Atlas: a FAIR community resource for experimentally derived proteoforms.

本文引用的文献

1
Quantitative analysis of peptides and proteins in biomedicine by targeted mass spectrometry.靶向质谱法在生物医学中对肽和蛋白质的定量分析。
Nat Methods. 2013 Jan;10(1):28-34. doi: 10.1038/nmeth.2309.
2
Interlaboratory reproducibility of selective reaction monitoring assays using multiple upfront analyte enrichment strategies.采用多种前体分析物富集策略的选择性反应监测分析的实验室间可重复性。
J Proteome Res. 2012 Aug 3;11(8):3986-95. doi: 10.1021/pr300014s. Epub 2012 Jul 3.
3
Mass spectrometric immunoassay of intact insulin and related variants for population proteomics studies.
人类蛋白质组图谱:一个用于实验衍生蛋白质组的 FAIR 社区资源。
Nucleic Acids Res. 2022 Jan 7;50(D1):D526-D533. doi: 10.1093/nar/gkab1086.
4
Proteomics and its applications in breast cancer.蛋白质组学及其在乳腺癌中的应用。
Am J Cancer Res. 2021 Sep 15;11(9):4006-4049. eCollection 2021.
5
Advances in Proteomic Techniques for Cytokine Analysis: Focus on Melanoma Research.蛋白质组学技术在细胞因子分析中的进展:以黑色素瘤研究为重点。
Int J Mol Sci. 2017 Dec 13;18(12):2697. doi: 10.3390/ijms18122697.
6
Mass Spectrometric Studies of Apolipoprotein Proteoforms and Their Role in Lipid Metabolism and Type 2 Diabetes.载脂蛋白蛋白异构体的质谱研究及其在脂质代谢和2型糖尿病中的作用
Proteomes. 2017 Oct 15;5(4):27. doi: 10.3390/proteomes5040027.
7
Assuring Consistent Performance of an Insulin-Like Growth Factor 1 MALDImmunoassay by Monitoring Measurement Quality Indicators.通过监测测量质量指标来确保胰岛素样生长因子 1 MALDI 免疫测定的一致性性能。
Anal Chem. 2017 Jun 6;89(11):6188-6195. doi: 10.1021/acs.analchem.7b01125. Epub 2017 May 10.
8
Mass Spectrometric Immunoassays in Characterization of Clinically Significant Proteoforms.质谱免疫分析在临床重要蛋白质变体表征中的应用
Proteomes. 2016 Mar 17;4(1):13. doi: 10.3390/proteomes4010013.
9
Mass spectrometric immunoassays for discovery, screening and quantification of clinically relevant proteoforms.用于发现、筛选和定量临床相关蛋白质变体的质谱免疫分析。
Bioanalysis. 2016 Aug;8(15):1623-1633. doi: 10.4155/bio-2016-0060. Epub 2016 Jul 11.
10
Transition from identity to bioactivity-guided proteomics for biomarker discovery with focus on the PF2D platform.从基于身份的蛋白质组学向生物活性导向的蛋白质组学转变以发现生物标志物,重点关注PF2D平台。
Proteomics Clin Appl. 2016 Jan;10(1):8-24. doi: 10.1002/prca.201500029. Epub 2015 Sep 16.
用于人群蛋白质组学研究的完整胰岛素及相关变异体的质谱免疫分析。
Proteomics Clin Appl. 2011 Aug;5(7-8):454-9. doi: 10.1002/prca.201000112. Epub 2011 Jun 8.
4
Comparison of modification sites formed on human serum albumin at various stages of glycation.比较糖化不同阶段人血清白蛋白上形成的修饰位点。
Clin Chim Acta. 2011 Jan 30;412(3-4):277-85. doi: 10.1016/j.cca.2010.10.018. Epub 2010 Oct 27.
5
High plasma levels of macrophage migration inhibitory factor are associated with adverse long-term outcome in patients with stable coronary artery disease and impaired glucose tolerance or type 2 diabetes mellitus.高血浆巨噬细胞移动抑制因子水平与稳定型冠状动脉疾病合并葡萄糖耐量受损或 2 型糖尿病患者的不良长期预后相关。
Atherosclerosis. 2010 Dec;213(2):573-8. doi: 10.1016/j.atherosclerosis.2010.09.004. Epub 2010 Sep 21.
6
Intrapersonal and populational heterogeneity of the chemokine RANTES.趋化因子 RANTES 的个体内和群体异质性。
Clin Chem. 2010 Sep;56(9):1432-41. doi: 10.1373/clinchem.2010.147884.
7
Validation of laboratory-developed molecular assays for infectious diseases.传染病的实验室研发分子检测的验证。
Clin Microbiol Rev. 2010 Jul;23(3):550-76. doi: 10.1128/CMR.00074-09.
8
Macrophage migration inhibitory factor: critical role in obesity, insulin resistance, and associated comorbidities.巨噬细胞移动抑制因子:在肥胖、胰岛素抵抗及相关合并症中的关键作用。
Mediators Inflamm. 2010;2010:610479. doi: 10.1155/2010/610479. Epub 2010 Feb 9.
9
Detection of endogenous B-type natriuretic peptide at very low concentrations in patients with heart failure.心力衰竭患者极低浓度内源性B型利钠肽的检测
Circ Heart Fail. 2008 Nov;1(4):258-64. doi: 10.1161/CIRCHEARTFAILURE.108.790774. Epub 2008 Oct 14.
10
Nutrient isothiocyanates covalently modify and inhibit the inflammatory cytokine macrophage migration inhibitory factor (MIF).营养异硫氰酸盐可共价修饰并抑制炎症细胞因子巨噬细胞移动抑制因子(MIF)。
Biochem J. 2009 Oct 12;423(3):315-21. doi: 10.1042/BJ20091170.